|
DCAF16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.78719999999588E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.631500E-02 |
| Normal-vs-Stage2 |
1.970190E-01 |
| Normal-vs-Stage3 |
9.30759913586598E-11 |
| Normal-vs-Stage4 |
3.03999999995419E-06 |
| Stage1-vs-Stage2 |
8.947400E-01 |
| Stage1-vs-Stage3 |
3.55300000531855E-08 |
| Stage1-vs-Stage4 |
1.580220E-03 |
| Stage2-vs-Stage3 |
1.235780E-02 |
| Stage2-vs-Stage4 |
6.286400E-02 |
| Stage3-vs-Stage4 |
4.309800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.5094999999985E-05 |
| Normal-vs-AfricanAmerican |
7.640200E-02 |
| Normal-vs-Asian |
5.495000E-01 |
| Caucasian-vs-AfricanAmerican |
2.896800E-01 |
| Caucasian-vs-Asian |
4.625600E-01 |
| AfricanAmerican-vs-Asian |
7.497200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72947999999007E-05 |
| Normal-vs-Female |
6.658600E-03 |
| Male-vs-Female |
5.906100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.476600E-03 |
| Normal-vs-Age(41-60Yrs) |
8.484800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.44209999994616E-06 |
| Normal-vs-Age(81-100Yrs) |
1.080200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.982200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.832400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.050000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.062400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.795000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.506400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.771900E-02 |
| Normal-vs-Grade 2 |
2.349600E-02 |
| Normal-vs-Grade 3 |
4.91550000036867E-07 |
| Normal-vs-Grade 4 |
1.65480000036133E-07 |
| Grade 1-vs-Grade 2 |
2.509800E-02 |
| Grade 1-vs-Grade 3 |
3.581000E-04 |
| Grade 1-vs-Grade 4 |
7.71179999999871E-05 |
| Grade 2-vs-Grade 3 |
1.316190E-03 |
| Grade 2-vs-Grade 4 |
2.353000E-04 |
| Grade 3-vs-Grade 4 |
1.333210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.043500E-02 |
| Normal-vs-ccB subtype |
7.604700E-04 |
| ccA subtype-vs-ccB subtype |
1.194440E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.719120E-03 |
| Normal-vs-N1 |
2.25279999999106E-05 |
| N0-vs-N1 |
4.854300E-02 |
|
|
